Plenge Gen

JANUARY 7, 2025

When I last wrote about AI on this blog three years ago, I spoke of it being a tool with the potential to transform scientific discovery, but the application I described was primarily theoretical. … The post AI Unleashed: Transforming Drug Discovery from Theory to Practice appeared first on Plenge Gen @rplenge.

Drugs 52

Drugs Production Research Drug Development 52

FDA Law Blog: Drug Discovery

MARCH 6, 2024

FDA Law Blog readers can use discount code S10-866-866L24.S Charles joined HP&M after more than a decade in biomedical research spent studying the neurobiological mechanisms of chronic pain and sensory processing. S for reduced registration fees. Just up the road in Boston on March 20-21, HP&M Associate Charles G.

FDA 59

FDA Compliance Pharmaceuticals Pharmaceutical Companies 59

Perficient: Drug Development

SEPTEMBER 26, 2023

But it’s a simple fact: Healthcare blogs provide significant opportunities to connect with your audience and drive conversions. If your healthcare organization doesn’t have an active healthcare blog, with articles written by your physicians, you’re missing out. Then write a blog article under the physician’s byline.

Marketing 52

Marketing Engineering Doctors Research 52

The Premier Consulting Blog

APRIL 13, 2025

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ 2] An overview of the 3Rs The FDA and other global regulatory health authorities have long embraced the 3Rs of animal research (replace, reduce, and refine).

Animal Testing 52

Animal Testing FDA Drug Development Production 52

thought leadership

MAY 29, 2023

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. These drugs often require significant investment in research and development, and their development requires careful project management.

Drug Development 52

Drug Development Pharma Companies Drugs Disease 52

Perficient: Drug Development

MARCH 5, 2024

We’ve written before about how crucial healthcare blogs can be to your organization’s messaging and outreach strategies. However, it’s not enough just to have a blog. But that number may be higher if you’re in a high-competition marketplace or you need to build up your blog content. Let’s walk through them.

Marketing 52

Marketing Research 52

Perficient: Drug Development

OCTOBER 3, 2023

Physician blogs are a great way to get your physicians’ messages out to the public. Blog articles that include your physicians’ bylines and consumer-friendly, understandable language help position your team of physicians as thought-leaders in their fields of expertise.

Doctors 52

Doctors Clinical Trials Marketing Engineering 52

addgene Blog

MARCH 21, 2024

Seeing inside these specimens has offered illumination on biochemical processes that are crucial in the world of biological research, medical therapy, and even drug development (Grimm & Lavis, 2022). If you’re struggling to select the right fluorescent tools, this blog is here to help.

Drug Development 105

Drug Development Therapies Research Drugs 105

FDA Law Blog: Biosimilars

APRIL 8, 2025

About one third of these PSGs are for complex products and many reflect what OGD and DPD learned about the science of equivalence from GDUFA-funded regulatory science research. Leading FDAs implementationof the Drug Competition Action Plan (DCAP). facilitating the twice annual updates to the Off-Patent, Off-Exclusivity List ).

FDA 144

FDA Drugs Production Drug Development 144

Alta Sciences

APRIL 11, 2024

What does change in drug development look like? aasimakopoulos Thu, 04/11/2024 - 23:52 HTML Disrupting the CRO Model: A 2024 Global Health Summit Documentary Can the drug development industry change for the better? Contact us to get started! What is the Global Health Summit? Discover the series. LET'S STAY CONNECTED!

Drug Development 52

Drug Development Drugs Research 52

Reprocell

OCTOBER 3, 2024

This blog is the second in a series exploring the critical role of safety pharmacology in drug discovery. In our previous post, we discussed the importance of human tissue studies in ensuring drug safety.

Research 59

Research Drug Development Drugs 59

DS in Pharmatics

APRIL 18, 2025

Discover the five pillars of drug development consulting: regulatory compliance, clinical trials, preclinical research, CMC, and market access.

Drug Development 52

Drug Development Clinical Trials Compliance Drugs 52

Alta Sciences

JANUARY 31, 2025

Guest Blog: Reflecting on the 2024 Society of Toxicology of Canada Symposium, by Ria Falvo, Director, Reporting pmjackson Fri, 01/31/2025 - 15:47 Ria Falvo, Director of Reporting, and Rina Massarelli, Associate Director of Safety Reporting, in Toronto, Ontario, for the 2024 STC Symposium. Tags Preclinical Research Weight 15

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

The Premier Consulting Blog

JANUARY 14, 2025

In this blog, we outline how the OCE gets involved in product reviews and offer a high-level summary of the programs and resources available for guiding oncology product development. Determining a new products pathway The OCE does not receive regulatory applications directly from sponsors who are developing new cancer therapies.

Clinical Trials 52

Clinical Trials Therapies FDA Trials 52

NIH Director's Blog: Drug Development

APRIL 2, 2020

The structural map of this interaction will help guide drug developers, atom by atom, in devising safe and effective ways to treat COVID-19. After confirmation by further research, these maps may well provide a basis for the design and development of therapeutics that specifically target this critical interaction.

Drug Development 52

Drug Development Drugs Science Medical Schools 52

FDA Law Blog: Drug Discovery

APRIL 21, 2025

One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a leadership vacuum at the Center for Drug Evaluation and Research (CDER).

FDA 64

FDA Drug Development Drugs International 64

FDA Law Blog: Drug Discovery

MAY 1, 2024

proudly announces the return of attorney Sarah Wicks to its drug development and compliance group. Sarah brings a wealth of experience and a proven track record of advising innovative drug and biologics companies through the intricate landscape of product development and commercialization.

Drug Development 52

Drug Development Molecular Biology Compliance Clinical Trials 52

The ChEMBL-og

DECEMBER 13, 2023

Assays des cribe the experimental set-up when testing the activity of drug-like compounds against biological targets; they provide useful context for researchers interested in drug-target relationships. Furthermore, publication of late-stage animal toxicity assays can provide an insight into the mechanism of drug toxicity.

Pharmacokinetics 125

Pharmacokinetics Drugs Drug Development Science 125

Predictive Oncology

AUGUST 8, 2024

In addition to the unpredictable costs associated with late-stage clinical trials, the typical timeline for moving from exhaustive basic research to regulatory approval is anywhere from ten to fifteen years. By combining these two assets, this offering represents an opportunity to de-risk drug discovery and accelerate pipeline development.

Drug Development 52

Drug Development Clinical Trials Animal Testing Drugs 52

Alta Sciences

JUNE 26, 2025

MENU logo-altasciences EN - Main navigation Proactive Drug Development Solutions Compare Us Facilities About Us Resource Center Careers News & Events 30th Anniversary Celebration Contact Us Participate in a study Français Home Current: Salt Lake City Salt Lake City Share this page Submitted by pmjackson on Thu, 06/26/2025 - 15:11 Image Downtown (..)

Pharmacokinetics 40

Pharmacokinetics Testimonials Biosimilars Drug Development 40

Crown Bioscience

AUGUST 2, 2021

In this blog we will explore immune-mediated inflammatory diseases (IMIDs) —which represent a diverse group of conditions characterized by an excessive and/or inappropriate immune response.

Disease 52

Disease Drug Development Immune Response Drugs 52

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment Drugs FDA Approval 52

Alta Sciences

JUNE 26, 2025

MENU logo-altasciences EN - Main navigation Proactive Drug Development Solutions Compare Us Facilities About Us Resource Center Careers News & Events 30th Anniversary Celebration Contact Us Participate in a study Français Home Current: Gretchen Green Gretchen Green Share this page Submitted by pmjackson on Thu, 06/26/2025 - 15:12 Image gretchen-green.jpg (..)

Pharmacokinetics 40

Pharmacokinetics Testimonials Biosimilars Drug Development 40

Perficient: Drug Development

APRIL 17, 2025

This blog series celebrates Perficients recognition as a 2025 USA Today Top Workplace. In our last blog, we discussed how Perficient is Shattering Boundaries through our global delivery model and cutting-edge strategies. By building strong relationships , we develop customized solutions that go above and beyond their expectations.

Science 64

Science Compliance Production Pharmaceuticals 64

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

Credit: National Institute of Allergy and Infectious Diseases, NIH A major part of NIH’s mission is to support basic research that generates fundamental knowledge about the nature and behavior of living systems. Previous attempts to quantify the contribution of federal funding to new drug development had looked primarily at patents.

Research 52

Research Science FDA Pharmaceutical Companies 52

FDA Law Blog: Drug Discovery

MARCH 3, 2025

This collaborative endeavor drives forward the most groundbreaking developments in advanced therapeutics, marrying scientific discovery with strategic business and legal acumen for global impact. FDA Law Blog is a conference media partner. Hyman, Phelps & McNamara, P.C.s As such, we can offer our readers a special 10% discount.

Compliance 52

Compliance FDA Marketing Therapies 52

NIH Director's Blog: Drug Development

OCTOBER 27, 2020

Another promising strategy is drugs that target the proteins within human cells that the virus needs to infect, multiply, and spread. Facilitated by the Quantitative Biosciences Institute Research Group, the team, which included David E. You can see one of these interactions in the video above.

Drug Development 52

Drug Development Drugs Virus Science 52

FDA Law Blog: Drug Discovery

JULY 17, 2024

An Opportunity to Leverage the Newly Created Rare Disease Advisory Committee across CDER and CBER In Frank and James’ 2018 proposal there was also a recommendation for the formation of a Rare Disease Advisory Committee, which would allow FDA access to experts in the science of small trials and other aspects of rare disease research.

FDA 105

FDA Disease Clinical Pharmacology Science 105

ACTO

DECEMBER 17, 2024

Part 2 Our first blog covered the ABCs of Artificial Intelligence (AI) and AIs evolution. These councils bring together diverse expertise from scientists and researchers, data analysts and technology specialists, regulatory compliance experts, as well as commercial operations leaders.

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52

Molecule Blog

JANUARY 9, 2023

The future of research is collaborative, digital, and highly autonomous. Research is built on data (and sometimes code) that routinely isn’t shared, affecting our ability to replicate science. How will IP-NFTs enable drug development in the future? Patents today are not.

Research 52

Research Licensing Licensing Science 52

Perficient: Drug Development

JUNE 13, 2023

In the process of researching site migration tools, I discovered “ Merlin ”. This makes it easier to break the site into pages that have similar DOM layouts (ie: blogs, news, products, etc) for the generate command. In a previous post, I shared my journey with Sitecore Data Exchange Framework. I ended up using Powershell.

Engineering 98

Engineering Production Marketing Research 98

Molecule Blog

MARCH 17, 2023

Moving research from concept to market is like conducting a symphony — there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. BioDAOs fund and incubate projects during the initial stages of translational research, often through IP-NFTs, even before a company is established.

Engineering 52

Engineering Research Clinical Trials Government 52

PPD

AUGUST 28, 2024

For pharmaceutical innovators and drug developers working to bring oncology therapies to market, patients are the “why” behind it all. Ultimately, a smooth trial process paves the way for the development of promising therapies that will continue to help more patients.

Trials 69

Trials Clinical Trials Drug Development Therapies 69

Conversations in Drug Development Trends

MAY 15, 2025

The Investigational New Drug (IND) application is a pivotal step in the drug development journey, offering a multitude of strategic advantages and enhanced opportunities. Have you considered the multiple associated benefits and implications in the context of your novel drug development plan?

Clinical Trials 52

Clinical Trials Drug Development FDA Trials 52

Alta Sciences

JULY 18, 2024

Issue 38 of The Altascientist explores the key considerations for successful formulation development and manufacture for safety assessment, alongside examining the strategies Altasciences employs to support you in planning your program. The Altascientist is a scientific journal written by the scientific and research experts at Altasciences.

Production 52

Production Clinical Trials Drugs Compliance 52

FDA Law Blog: Drug Discovery

FEBRUARY 27, 2025

Implications for Future of Clinical Research R3 represents an important evolution in GCP, shifting away from a prescriptive model toward a more flexible, risk-based approach.

Clinical Trials 88

Clinical Trials Trials Clinical Research Government 88

Perficient: Drug Development

DECEMBER 30, 2024

This blog post will serve as a comprehensive introduction to Generative AI, guiding you through its foundational concepts and exploring the groundbreaking features of ChatGPT. Example: Imagine you’re writing a blog post about the benefits of meditation. Generative AI is rapidly transforming the world around us.

Production 52

Production Drugs Research 52